Pharmaceutical Anti-Counterfeiting Technologies: Market Analysis And Forecasts 2015-2025

偽造医薬品対策技術の世界市場:バーコード、RFID、タグ、ホログラム/OVD等

◆タイトル:Pharmaceutical Anti-Counterfeiting Technologies: Market Analysis And Forecasts 2015-2025
◆商品コード:VGAIN4121904
◆調査・発行会社:visiongain
◆発行日:2014年12月
◆ページ数:242
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserGBP1,799 ⇒換算¥269,850見積依頼/購入/質問フォーム
Five UsersGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、偽造医薬品対策技術の世界市場について調査・分析し、レポートサマリー、市場概要、世界市場分析(市場規模、市場予測、促進要因、抑制要因)、セグメント別分析、主要地域別分析、技術分析、市場環境分析、専門家の見解、主要企業分析、結論などの情報をお届けいたします。

Pharmaceutical Anti-counterfeiting Technologies – new study showing you trends, R&D progress, and predicted revenues
Where’s the pharmaceutical anti-counterfeiting technologies market heading? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 242-page report provides 126 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and STEP Analysis), company profiles and commercial developments.

Read the full transcripts of six exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Dave Coons, VP of Advanced Markets and Technology; Laurie Eldridge-Shanaman, Director, Global Healthcare Practice; Clive Hohberger; Previously VP of Technology Development at Zebra Technologies
- Ryon Packer, Chief Marketing Officer and General Manager at Authentix
- Dr Michael Hogan, Vice President of Life Sciences at Applied DNA Sciences
- Mike Messmer, General Manager at NovaVision
- Dr Fred Jordan, Chief Executive Officer at AlpVision
- Spokesperson from a leading anti-counterfeiting technologies company based in the US

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2025 for these five submarkets:
• Barcodes
• RFID
• Holograms/OVD
• Taggants
• Other anti-counterfeiting technologies

With our investigation you gain business research and analysis with submarkets sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints affecting each submarket. See what’s likely to achieve the most success.

You gain competitive advantages by understanding the dynamics, opportunities and challenges facing the pharmaceutical anti-counterfeiting technologies market. As well as finding technologies that will likely to achieve the most success.

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 8 regional markets to 2025:
• US
• EU5
• Japan
• China
• India
• Brazil
• Russia
• Mexico
• Rest of the World

There will be growth in established and developing pharma markets. Our analyses show that the US, China, India, Mexico and Brazil, in particular, will continue to achieve high revenue growth to 2025. Developments worldwide, mandatory government requirements and rising awareness of counterfeit drugs will influence the market.

Many opportunities exist for security companies developing anti-counterfeiting technologies. You can assess the industry’s future – hear about developments and find their significance in our analytical report.

Leading companies and potential for market growth
Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $3.4bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Rising consumption of counterfeit drugs, government regulatory mandates and FDA initiatives, technological advancements and the rapid growth of the RFID submarket will drive sales to 2025.

Our work shows you which companies hold the greatest potential. See profiles of 16 leading companies, including these:
• 3M
• Alien Technology
• AlpVision
• Angstrom Technologies
• Authentix
• Avery Dennison
• Colorcon
• Covectra
• Everest Holovisions
• InkSure Technologies
• Intermec
• Multi Packaging Solutions
• ThermoFisher Scientific
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

【レポートの目次】

1. Report Overview
1.1 Pharmaceutical Anti-counterfeiting Technologies Market Highlights
1.2 World Pharmaceutical Anti-counterfeiting Technologies Market Breakdowns by Technology and Region
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Counterfeiting
2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Worldwide Counterfeiting Incidents
2.1.3 Highest Counterfeiting Incidents in Asia and Europe in 2013
2.2 What are the Most Commonly Counterfeited Drugs?
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.5 Methods of Producing Pharmaceutical Counterfeits
2.5.1 Moving Counterfeits into the Pharmaceutical Supply Chain
2.5.2 Corruption Within the Pharmaceutical Distribution System
2.6 The Internet and Its Role in Pharmaceutical Counterfeiting
2.6.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.6.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.6.3 Verifying the Authenticity of Online Pharmacies
2.7 Pharmaceutical Counterfeiting: The Global Costs
2.7.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.7.2 The Impact of Counterfeiting on Healthcare Providers
2.7.3 The Impact of Counterfeiting on Pharma Manufacturers
2.7.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.7.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.8 Operation Pangea: Europol’s Fight Against Counterfeiting
2.8.1 Legislative Deficiencies Aiding Counterfeiting Operations
2.9 Factors Fuelling Pharmaceutical Counterfeiting
2.9.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.9.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.9.3 Drug Misuse Creates a Market for Counterfeiting
2.9.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.9.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.9.6 Counterfeiters Target Developed Markets
2.9.7 Parallel Trade – a Counterfeiting Route in Europe
2.10 Leading Anti-counterfeiting Technologies and Applications
2.10.1 Passive Anti-counterfeiting Technologies
2.10.1.1 Holograms
2.10.1.2 Security Inks
2.10.1.3 Overt and Hidden Imaging
2.10.1.4 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
2.10.2 Active Anti-counterfeiting Technologies
2.10.2.1 Radio Frequency Identification (RFID)
2.10.2.1 Taggants
2.10.3 Mass Encoding Technologies
2.10.3.1 Digital Mass Serialisation Technology (DMS)
2.10.3.2 Digital Mass Encryption (DME)
2.10.3.3 Barcodes

3. Pharmaceutical Anti-counterfeiting Technologies: World Market 2015-2025
3.1 World Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
3.1.1 Breakdown of the World Pharmaceutical Anti-counterfeiting Technologies Market by Technology in 2013 and 2014
3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2015-2025
3.2.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2013-2019
3.2.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2019-2025
3.3 RFID Lead the World Pharmaceutical Anti-counterfeiting Technologies Market
3.4 Market Attractiveness Forecasts of Leading Pharmaceutical Anti-counterfeiting Technologies in 2019 and 2025
3.5 How Will Segmental Market Shares Change to 2025?
3.6 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints 2015-2025

4. Leading National Markets 2015-2025
4.1 Geographical Breakdown of the World Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.2 World Pharmaceutical Anti-counterfeiting Technologies Market: National Markets Forecast 2015-2025
4.2.1 Market Attractiveness Forecasts of Leading Pharmaceutical Anti-counterfeiting National Markets in 2019 and 2025
4.2.1.1 Market Attractiveness Forecasts of Developed Countries in 2019 and 2025
4.2.1.2 Market Attractiveness Forecasts of Emerging Countries in 2019 and 2025
4.2.2 How Will National Market Shares Change to 2025?
4.3 US Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.3.1 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.3.2 US Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.3.2.1 Drug Supply Chain Security Act of 2013
4.4 EU5 Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.4.1 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.4.2 EU5 Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.4.2.1 EU Enforcement of Drug Serialisation by 2016
4.5 Japanese Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.5.1 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.5.2 Japanese Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.5.2.1 Japan’s Uptake of Anti-counterfeiting Technologies
4.6 Chinese Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.6.1 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.6.2.1 Chinese Anti-Counterfeiting Measures From Past to Present
4.7 Indian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.7.1 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.7.2 Indian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.7.2.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products
4.8 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.8.1 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.8.2 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.8.2.1 Brazilian Anti-Counterfeiting Measures From Past to Present
4.9 Russian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.9.1 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.9.2 Russian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.9.2.1 Russian Anti-Counterfeiting Measures From Past to Present
4.10 Mexican Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.10.1 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.10.2 Mexican Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.10.2.1 Mexico Signs the ACTA

5. Pharmaceutical Barcodes Market 2015-2025
5.1 Barcodes as Anti-counterfeiting Technology
5.2 Pharmaceutical Barcodes Market in 2013 and 2014
5.3 Pharmaceutical Barcodes Market: Sales Forecast 2015-2025
5.4 Pharmaceutical Barcodes Market: Drivers and Restraints 2015-2025

6. Pharmaceutical RFID Market 2015-2025
6.1 RFID as Anti-counterfeiting Technology
6.2 Pharmaceutical RFID Market in 2013 and 2014
6.3 Pharmaceutical RFID Market: Sales Forecast 2015-2025
6.4 Pharmaceutical RFID Market: Drivers and Restraints 2015-2025
6.4.1 Driver: Benefits of RFID Track-and-Trace in the Pharma Industry
6.4.2 Driver: Brand Protection and Prevention of Revenue Loss
6.4.3 Restraint: Threat of Information Leakage with Passive RFID Tags
6.4.4 Restraint: High Initial Outlay of RFID Systems

7. Pharmaceutical Taggants Market 2015-2025
7.1 Taggants as Anti-counterfeiting Technology
7.1.1 Types of Taggants and Their Authentication Methods
7.2 Pharmaceutical Taggants Market in 2013 and 2014
7.3 Pharmaceutical Taggants Market: Sales Forecast 2015-2025
7.4 Pharmaceutical Taggants Market: Drivers and Restraints 2015-2025

8. Pharmaceutical Holograms/OVD Market 2015-2025
8.1 Holograms/OVD as Anti-counterfeiting Technology
8.2 Pharmaceutical Holograms/OVD Market in 2013 and 2014
8.3 Pharmaceutical Holograms/OVD Market: Sales Forecast 2015-2025
8.4 Pharmaceutical Holograms/OVD Market: Drivers and Restraints 2015-2025
8.5 Other Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2015-2025

9. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market
9.1 Leading Pharmaceutical Anti-counterfeiting Technology Manufacturers by Segment in 2014
9.2 3M At a Glance
9.2.1 3M: Pharma Anti-counterfeiting Technology Portfolio
9.3 Alien Technology At a Glance
9.3.1 Alien Technology: Pharma Anti-counterfeiting Technology Portfolio
9.3.2 Alien Technology: Recent Developments
9.3.2.1 New Partnership and Securing Investments
9.3.2.2 New Products Launch
9.4 AlpVision At a Glance
9.4.1 AlpVision: Pharma Anti-counterfeiting Technology Portfolio
9.4.3 AlpVision: Recent Developments
9.4.3.1 Integration of Phone Applications Important for Future Growth
9.5 Angstrom Technologies At a Glance
9.5.1 Angstrom Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.6 Authentix At a Glance
9.6.1 Authentix: Pharma Anti-counterfeiting Technology Portfolio
9.6.1.1 Product-specific Track-and-Trace Solutions
9.6.1.2 Packaging Solutions
9.7 Avery Dennison At a Glance
9.7.1 Avery Dennison: Pharma Anti-counterfeiting Technology Portfolio
9.7.2 Avery Dennison: Financial Overview
9.8 Colorcon At a Glance
9.8.1 Colorcon: Pharma Anti-counterfeiting Technology Portfolio
9.8.1.1 Colorcon’s Taggants: On-Dose ID
9.8.2 Colorcon: Recent Developments
9.8.2.1 Investing For the Future in South Asia
9.9 Covectra At a Glance
9.9.1 Covectra: Pharma Anti-counterfeiting Technology Portfolio
9.9.1.1 Covectra’s Authenti-Track System for Product Tracing
9.9.1.2 Covectra’s ControlTrack System for Combating Opioid Drug Diversion
9.9.2 Covectra: Recent Developments
9.9.2.1 Establishing European Presence
9.10 Everest Holovisions At a Glance
9.11 InkSure Technologies At a Glance
9.11.1 InkSure Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.11.2 InkSure Technologies: Financial Overview
9.11.3 InkSure Technologies: Recent Developments
9.11.3.1 InkSure Completes Purchase Agreement to Sell Assets
9.12 Intermec At a Glance
9.12.1 Intermec: Pharma Anti-counterfeiting Technology Portfolio
9.12.2 Intermec: Financial Overview
9.12.3 Intermec: Recent Developments
9.12.3.1 Acquisition of Intermec by Honeywell
9.13 Multi Packaging Solutions At a Glance
9.13.1 MPS: Pharma Anti-counterfeiting Technology Portfolio
9.13.2 MPS: Recent Developments
9.13.2.1 MPS’s Mergers and Acquisitions
9.14 ThermoFisher Scientific At a Glance
9.14.1 ThermoFisher Scientific: Pharma Anti-counterfeiting Technology Portfolio
9.14.1.1 ThermoFisher Scientific’s TruScan Technology
9.14.2 ThermoFisher Scientific: Financial Overview
9.14.3 ThermoFisher Scientific: Recent Developments
9.14.3.1 ThermoFisher Scientific’s Mergers and Acquisitions
9.15 TruTag Technologies At a Glance
9.15.1 TruTag Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.15.1.1 TruTag’s Silica Microtag Technology
9.15.2 TruTag Technologies: Recent Developments
9.15.2.1 Investment from WuXi PharmaTech
9.16 UPM Raflatac At a Glance
9.16.1 UPM Raflatac: Pharma Anti-counterfeiting Technology Portfolio
9.16.2 UPM Raflatac: Recent Developments
9.16.2.1 Smartrac Takeover of UPM Raflatac’s RFID Business
9.17 Zebra Technologies At a Glance
9.17.1 Zebra Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.17.2 Zebra Technologies: Financial Overview
9.17.3 Zebra Technologies: Recent Developments
9.17.3.1 Zebra Acquire Enterprise Business from Motorola Solutions
9.17.3.2 Zebra Acquire Hart Systems
9.17.3.3 Zebra Launch of Zatar

10. Qualitative Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025
10.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025
10.2 Strengths
10.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
10.2.1.1 AstraZeneca
10.2.1.2 GlaxoSmithKline (GSK)
10.2.1.3 Johnson & Johnson (J&J)
10.2.1.4 Novartis
10.2.1.5 Pfizer
10.2.1.6 Sanofi
10.2.2 Organisations Promoting Awareness and Implementation of Anti-counterfeiting Solutions
10.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
10.2.2.2 Anti-counterfeiting Group (ACG)
10.2.2.3 Brazil’s National Health Surveillance Agency (ANVISA)
10.2.2.4 Canadian Anti-counterfeiting Network (CACN)
10.2.2.5 Centre for Healthcare Supply Chain Research
10.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
10.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
10.2.2.8 International Anti-counterfeiting Coalition (IACC)
10.2.2.9 International Authentication Association (IAA)
10.2.2.10 Pharmaceutical Security Institute (PSI)
10.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
10.2.4 New Technologies Providing More Comprehensive Anti-counterfeiting Protection
10.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
10.3 Weaknesses
10.3.1 Lack of Standardisation Across the Industry Will Impede Technology Adoption
10.3.2 Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies
10.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult
10.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
10.3.4 Lack of Cooperation Between Governmental Organisations Aid Drug Counterfeiters
10.4 Opportunities
10.4.1 Constantly Evolving Technologies Allows for Product Innovation
10.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
10.5 Threats
10.5.1 High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting Solutions
10.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
10.5.3 Rate of Innovation May be Outpaced by Counterfeiters
10.6 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025
10.7 Social Factors
10.7.1 Weak Enforcement of Legislation
10.7.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
10.7.3 Changing Public Perception and Consumer Education
10.7.4 Concerns Over Information Privacy
10.8 Technological Factors
10.8.1 Smartphone Read and Verify: A Customer Empowerment Tool
10.8.2 US FDA Counterfeit Detection Device
10.8.3 UV and IR Inks Being Used Covertly for Increased Security
10.8.4 Bokode: A Potential Replacement for Barcodes?
10.8.5 SigNature DNA
10.9 Economic Factors
10.9.1 Implementation Costs of Anti-counterfeiting Technologies
10.9.2 Anti-counterfeiting Technologies Require R&D Investment
10.10 Political Factors
10.10.1 WHO: The IMPACT Programme
10.10.2 Anti-Counterfeiting Trade Agreement (ACTA)
10.10.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain
10.10.4 Legislations for Supply Chain Security
10.10.5 E-pedigree: Catalyst for Product Serialisation
10.10.5.1 E-pedigree: Challenges Involved in Implementation
10.10.5.2 EU and US: Differing Supply Chain Authentication
10.10.6 UK MHRA: Falsified Medical Products Strategy
10.10.7 EU’s Falsified Medicines Directive

11. Research Interviews
11.1 Interview with Representatives of Zebra Technologies
11.1.1 Zebra’s Key Technologies and Strategies for Combating Counterfeiters
11.1.2 Country of Largest Counterfeiting Threat
11.1.3 Size and Growth Rate of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.1.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.1.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.1.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.1.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.2 Interview with Ryon Packer, Chief Marketing Officer and General Manager of Authentix
11.2.1 Authentix’s Key Technologies and Strategies for Combating Counterfeiters
11.2.2 Size and Growth Rate of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.2.3 Which is Dominating: Barcode or RFID?
11.2.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.2.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.2.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.2.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.3 Interview with Dr Michael Hogan, Vice President of Life Sciences at Applied DNA Sciences
11.3.1 Applied DNA Sciences’ Key Technologies and Strategies for Combating Counterfeiters
11.3.1.1 DNA Labelling Authentication Solution
11.3.1.2 Practicalities of On and In Product DNA Labelling
11.3.2 Applied DNA Sciences Entering the Pharmaceutical Anti-counterfeiting Scene
11.3.3 Current Dominating Anti-Counterfeiting Technology
11.3.4 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.4 Interview with Mike Messmer, General Manager of NovaVision
11.4.1 NovaVison’s Key Technologies and Strategies for Combating Counterfeiters
11.4.2 Country of Largest Counterfeiting Threat
11.4.3 Size of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.4.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.4.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.4.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.4.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.5 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
11.5.1 Current State of Counterfeiting in the Pharmaceutical Industry
11.5.2 AlpVison’s Key Technologies and Strategies for Combating Counterfeiters
11.5.3 Future of Anti-counterfeiting Technologies
11.5.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
11.5.5 Major Barriers Facing Implementation of Anti-counterfeiting Technologies
11.5.6 Future Drivers of the Anti-counterfeiting Technologies Market
11.6 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US
11.6.1 Threats Posed by Counterfeit Products
11.6.2 Keeping Up with Counterfeiters: An Impossible Task?
11.6.3 Duty of Care
11.6.4 DNA Technology: Innovation Needed to Defeat Counterfeiting?
11.6.5 Future Prospects of the Pharma Anti-counterfeiting Industry

12. Conclusions
12.1 Pharmaceutical Anti-counterfeiting Technologies: A Growing Market
12.2 Leading Pharmaceutical Anti-counterfeiting Technologies Submarkets in 2014
12.3 Leading National Markets in 2014
12.4 The Future of the Pharmaceutical Anti-counterfeiting Technologies Market?
12.4.1 Government Mandates Will Fuel Growth in the Market
12.4.2 The US Will Continue to Dominate the Market
12.4.3 New Directives Will Ensure Track-and-Trace Market Leadership
12.4.4 European Preference for Mandated 2D Barcode Technology
12.4.5 Enhanced Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective
12.4.6 Market Expansion Will be Dependent on the Development of Industry-wide Standards
12.4.7 What Will Succeed in the Pharmaceutical Anti-counterfeiting Technologies Market?

13. Glossary

List of Tables
Table 1.1 Leading National Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025 ($m, AGR%)
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Table 2.2 Global Reported Incidents of Drug Counterfeiting by Region & Regional Percentage (%), 2013
Table 2.3 Classification of Counterfeit Pharmaceutical Products
Table 2.4 Characteristics of an Ideal Anti-counterfeiting Technology
Table 2.5 Advantages and Disadvantages of Overt and Covert Technologies
Table 2.6 Types of Anti-counterfeiting Technologies Used in the Pharmaceutical Industry by Category
Table 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013 and 2014
Table 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Technology in 2013-2019, 2019-2025 and 2013-2025
Table 3.4 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) by Technology, 2019
Table 3.5 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) by Technology, 2025
Table 3.6 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Technology, 2014, 2019 and 2025
Table 4.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013 and 2014
Table 4.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2013-2025
Table 4.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Region in 2013-2019, 2019-2025 and 2013-2025
Table 4.4 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) of Developed Countries, 2019 and 2025
Table 4.5 Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) of Emerging Countries, 2019 and 2025
Table 4.6 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Region, 2014, 2019 and 2025
Table 4.7 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.8 Susceptibility of the EU5 Countries to Drug Counterfeiting, 2014
Table 4.9 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.10 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.11 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.12 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.13 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.14 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.15 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 5.1 Comparison of 2D Barcode and RFID Technology
Table 5.2 Barcodes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 6.1 RFID Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 7.1 Taggants Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 8.1 Holograms/OVD Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 8.2 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 9.1 Leading RFID Technology Manufacturers, 2014
Table 9.2 Leading Holographic Labelling Technology Manufacturers, 2014
Table 9.3 Leading Taggants Technology Manufacturers, 2014
Table 9.4 Other Leading Anti-counterfeiting Technology Manufacturers, 2014
Table 9.5 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2013
Table 9.6 3M Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.7 Alien Technologies: Portfolio of RFID Readers, 2014
Table 9.8 Alien Technologies: Portfolio of RFID Inlays and Their Relative Performances in Pharma Applications, 2014
Table 9.9 AlpVision: Portfolio of Pharmaceutical Anti-counterfeiting Solutions, 2014
Table 9.10 Angstrom Technologies: Portfolio of Anti-counterfeiting Solutions, 2014
Table 9.11 Avery Dennison: Portfolio of RFID Inlays for Use in Pharmaceuticals, 2014
Table 9.12 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2013
Table 9.13 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.14 Colorcon: Portfolio of Product Groups, Sub-groups, and Examples, 2014
Table 9.15 Everest Holovision: Portfolio of Products and Applications, 2014
Table 9.16 InkSure Technologies: Portfolio of Products and Applications, 2014
Table 9.17 InkSure Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.18 Intermec: Portfolio of Products and Descriptions, 2014
Table 9.19 Honeywell (acquired Intermec in 2013) Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.20 ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.21 ThermoFisher Scientific: Revenues ($m), Revenue Shares (%) by Business Segment, 2013
Table 9.22 UPM Raflatac: Portfolio of Product Groups and Descriptions, 2014
Table 9.23 Zebra Technologies: Portfolio of Product Groups and Descriptions, 2014
Table 9.24 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 10.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2015-2025
Table 10.2 Selected Instances of Counterfeiting Activities, 2009-2014
Table 10.3 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2015-2025

List of Figures
Figure 1.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Figure 1.2 World Anti-counterfeiting Market Segmentation by Technology Overview
Figure 1.3 World Anti-counterfeiting Market Segmentation by Region Overview
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Figure 2.2 Global Reported Incidents of Drug Counterfeiting by Region, 2013
Figure 2.3 Global Reported Incidents of Drug Counterfeiting by Regional Percentage (%), 2013
Figure 2.4 Most Common Types of Drugs Counterfeited in Developed and Emerging Countries, 2014
Figure 2.5 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 2.6 Basic Components of a RFID System
Figure 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013
Figure 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2014
Figure 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), AGR (%), 2013-2025
Figure 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013-2025
Figure 3.5 World Pharmaceutical Anti-counterfeiting Market Forecast: Revenue ($m), CAGR (%), by Technology 2013 and 2025
Figure 3.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2013-2019 and 2019-2025
Figure 3.7 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2013-2025
Figure 3.8 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%) by Technology, 2019
Figure 3.9 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%) by Technology, 2025
Figure 3.10 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2014
Figure 3.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2019
Figure 3.12 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2025
Figure 3.13 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints, 2015-2025
Figure 4.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013
Figure 4.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2014
Figure 4.3 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013-2025
Figure 4.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), CAGR (%), by Region, 2013 and 2025
Figure 4.5 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Region in 2013-2019 and 2019-2025
Figure 4.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Region in 2013-2025
Figure 4.7 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Developed Countries, 2019
Figure 4.8 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Developed Countries, 2025
Figure 4.9 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Emerging Countries, 2019
Figure 4.10 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Emerging Countries, 2025
Figure 4.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2014
Figure 4.12 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2019
Figure 4.13 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2025
Figure 4.14 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.15 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.16 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.17 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.18 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.19 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.20 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.21 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 5.1 Barcodes Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 5.2 Barcodes Market Forecast: Drivers and Restraints, 2015-2025
Figure 6.1 RFID Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 6.2 RFID Market Forecast: Drivers and Restraints, 2015-2025
Figure 7.1 Taggants Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 7.2 Taggants Market Forecast: Drivers and Restraints, 2015-2025
Figure 8.1 Holograms/OVD Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 8.2 Holograms/OVD Market Forecast: Drivers and Restraints, 2015-2025
Figure 8.3 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 9.1 3M: Revenue Shares (%) by Business Segment, 2013
Figure 9.2 3M Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.3 Authentix’s Global Monitoring Service: A Three Step Programme
Figure 9.4 Avery Dennison: Revenue Shares (%) by Business Segment, 2013
Figure 9.5 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.6 InkSure Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.7 Honeywell (acquired Intermec in 2013) Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.8 ThermoFisher Scientific Historical Sales: Revenue ($bn), AGR (%), 2009-2013
Figure 9.9 ThermoFisher Scientific: Revenue Shares (%) by Business Segment, 2013
Figure 9.10 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 10.1 EU Supply Chain Authentication Strategy, 2014
Figure 10.2 US Supply Chain Authentication Strategy, 2014
Figure 12.1 Top Five National Pharmaceutical Anti-counterfeiting Technologies Markets: Revenues ($m), 2014 & 2025

【レポートのキーワード】

偽造医薬品対策技術、製薬、バーコード、RFID、タグ、ホログラム、OVD

★調査レポート[偽造医薬品対策技術の世界市場:バーコード、RFID、タグ、ホログラム/OVD等] ( Pharmaceutical Anti-Counterfeiting Technologies: Market Analysis And Forecasts 2015-2025 / VGAIN4121904) 販売に関する免責事項
[偽造医薬品対策技術の世界市場:バーコード、RFID、タグ、ホログラム/OVD等] ( Pharmaceutical Anti-Counterfeiting Technologies: Market Analysis And Forecasts 2015-2025 / VGAIN4121904) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆